Research shows that Andrographis paniculata extract has potential health benefits of Alzheimer's disease

Recently, the Andrographis paniculata extract (http:// of HP ingredients (http:// obtained the EU patent (http:// Recent animal studies have shown that Andrographis paniculata extract has potential health benefits for Alzheimer's disease (http:// It is reported that the EU approved patent is named "andrographolide for Alzheimer's disease treatment and cognitive repair", which is also the health claim of andrographolide Andrographolide is extracted from the stems and leaves of andrographolide, which is claimed to be "a method for the treatment of dementia in human Alzheimer's disease, in which the effective amount of andrographolide is 1-4mg / kg orally" The application materials submitted by HP company include the clinical research materials conducted by HP company, which found that andrographolide can prevent or even reverse the neuropathy of Alzheimer's disease mouse model It was found that andrographolide could restore the spatial memory function of mice, decrease the content of amyloid β - peptide (a β) and increase the excitatory postsynaptic potential In the patent application, the researchers believe that the results show that andrographolide can be used as a potential preventive and reversible treatment in the progression of Alzheimer's disease HP's Andrographis extract has been successively supported by FDA (http:// and EU, indicating that more technology research accumulation can help to formulate specific claims Although FDA is very strict in the control of neuroactin, EU patent acquisition is encouraging He supports neuroactin as a supplement to support healthy brain structure and function, improve cognitive acuity and memory